VDR and type 2 diabetes mellitus: de Zeeuw, D., et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlledtrial. Lancet 376, 1543–1551 (2010).